CASSIDY REIMUND: Open Payments
NPI 1699301481 · WATKINSVILLE, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$695 in 29 payments from 16 companies in 2025. Trend: 2023 $725 · 2024 $1,034 · 2025 $695
Food & beverage: $695
| Company | Payments | Amount |
|---|---|---|
| Sumitomo Pharma America, Inc. | 3 | $76 |
| Ferring Pharmaceuticals Inc. | 3 | $64 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $57 |
| Astellas Pharma US Inc | 2 | $56 |
| Dendreon Pharmaceuticals LLC | 2 | $55 |
| UROGEN PHARMA, INC. | 2 | $55 |
| Janssen Biotech, Inc. | 2 | $55 |
| ABBVIE INC. | 2 | $55 |
| Verity Pharmaceuticals Inc. | 3 | $54 |
| PFIZER INC. | 2 | $44 |
Products named: Xtandi, ADSTILADRIN, Nubeqa, PROVENGE, ERLEADA, BOTOX, Trelstar, ORGOVYX.
Industry payments across GA — which companies pay providers there.
